CAT and prostate carcinoma: CAT rs7943316 and GPX-1 rs1050450 polymorphisms alter their antioxidant capacity and associated with different kinds of diseases such as Kashin-Beck (37), prostate cancer (38), peripheral neuropathy (39), diabetes mellitus (16) recurrent miscarriage (40), and brain tumors (41).